BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.12) earnings per share (EPS) for the quarter, FiscalAI reports. BioNexus Gene Lab had a negative net margin of 54.70% and a negative return on equity of 37.43%. The firm had revenue of $0.08 million for the quarter.
BioNexus Gene Lab Stock Performance
BGLC stock traded down $0.07 during trading on Friday, reaching $1.57. 2,135 shares of the company’s stock were exchanged, compared to its average volume of 50,603. The company has a quick ratio of 5.69, a current ratio of 6.53 and a debt-to-equity ratio of 0.01. BioNexus Gene Lab has a 1-year low of $1.07 and a 1-year high of $6.10. The company’s fifty day moving average price is $1.87 and its 200-day moving average price is $2.14. The firm has a market cap of $3.80 million, a PE ratio of -1.06 and a beta of 4.16.
Analyst Ratings Changes
Separately, Weiss Ratings raised shares of BioNexus Gene Lab from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, August 5th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company presently has an average rating of “Sell”.
Institutional Investors Weigh In On BioNexus Gene Lab
An institutional investor recently raised its position in BioNexus Gene Lab stock. DRW Securities LLC boosted its stake in BioNexus Gene Lab Corp. (NASDAQ:BGLC – Free Report) by 226.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,830 shares of the company’s stock after buying an additional 33,179 shares during the period. DRW Securities LLC owned 2.02% of BioNexus Gene Lab worth $189,000 at the end of the most recent quarter. 18.85% of the stock is currently owned by institutional investors.
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Featured Stories
- Five stocks we like better than BioNexus Gene Lab
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.
